Prevention of Depression With Escitalopram in Patients Undergoing Treatment for Head and Neck CancerRandomized, Double-blind, Placebo-Controlled Clinical TrialEscitalopram for Depression Prevention
Open Access
- 20 June 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 139 (7) , 678-686
Abstract
Head and neck cancer (HNC) accounts for 4% of all cancers in the United States and is the fifth most common type of cancer worldwide.1 The term HNC is the collective name for cancers that affect the oral cavity, paranasal sinuses, pharynx, larynx, skin, and salivary glands, 95% of which are epidermoid carcinomas. The incidence of HNC of the oropharynx is increasing worldwide because of the epidemic of human papillomavirus-associated cancer and is increasing the global burden and importance of this disease.2 Curative treatment consists of either surgery or radiation as the primary modality for early-stage disease.3 For more advanced disease, combination therapies using surgery, radiation, and chemotherapy are used.4-7 The burden of treatment is extensive and frequently includes dysphagia, disfigurement, voice alterations, mucositis, need for tracheostomy and feeding tubes, fatigue, and depression.8,9 Mitigation of these adverse effects and enhancement of survivorship are important goals of caregivers and researchers alike.Keywords
This publication has 30 references indexed in Scilit:
- Symptoms of depression in patients with cancer of the head and neck undergoing radiotherapy treatment: a prospective studyRevista Latino-Americana de Enfermagem, 2012
- Cancers with increasing incidence trends in the United States: 1999 through 2008CA: A Cancer Journal for Clinicians, 2012
- Controversies in the locoregional management of head and neck cancer.Journal of the National Comprehensive Cancer Network, 2011
- HPV & head and neck cancer: a descriptive updateHead & Neck Oncology, 2009
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2004
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 2004
- Psychological distress in patients with head and neck cancer: reviewBritish Journal of Oral and Maxillofacial Surgery, 2001
- Health-related quality of life three years after diagnosis of head and neck cancer?A longitudinal studyHead & Neck, 2001
- A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patientsBritish Journal of Cancer, 1999
- A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapyOral Oncology, 1997